PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pioglitazone Hydrochloride And Glimepiride, and what generic alternatives are available?
Pioglitazone Hydrochloride And Glimepiride is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE is glimepiride; pioglitazone hydrochloride. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glimepiride; pioglitazone hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE?
- What are the global sales for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE?
- What is Average Wholesale Price for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE?
Summary for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 20 |
| DailyMed Link: | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE at DailyMed |
Recent Clinical Trials for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Seoul National University Hospital | Phase 4 |
| Kanazawa University | Phase 4 |
| Kowa Company, Ltd. | Phase 4 |
See all PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE clinical trials
Pharmacology for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
US Patents and Regulatory Information for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE | glimepiride; pioglitazone hydrochloride | TABLET;ORAL | 201049-001 | Jan 4, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE | glimepiride; pioglitazone hydrochloride | TABLET;ORAL | 201049-002 | Jan 4, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
